FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1617971501> ?p ?o ?g. }

• W1617971501 endingPage "e0133877" @default.
• W1617971501 startingPage "e0133877" @default.
• W1617971501 abstract "Without a doubt, our current antimicrobials are losing the battle in the fight against newly-emerged multidrug-resistant pathogens. There is a pressing, unmet need for novel antimicrobials and novel approaches to develop them; however, it is becoming increasingly difficult and costly to develop new antimicrobials. One strategy to reduce the time and cost associated with antimicrobial innovation is drug repurposing, which is to find new applications outside the scope of the original medical indication of the drug. Ebselen, an organoselenium clinical molecule, possesses potent antimicrobial activity against clinical multidrug-resistant Gram-positive pathogens, including Staphylococcus, Streptococcus, and Enterococcus, but not against Gram-negative pathogens. Moreover, the activity of ebselen against Gram-positive pathogens exceeded those activities determined for vancomycin and linezolid, drugs of choice for treatment of Enterococcus and Staphylococcus infections. The minimum inhibitory concentrations of ebselen at which 90% of clinical isolates of Enterococcus and Staphylococcus were inhibited (MIC90) were found to be 0.5 and 0.25 mg/L, respectively. Ebselen showed significant clearance of intracellular methicillin-resistant S. aureus (MRSA) in comparison to vancomycin and linezolid. We demonstrated that ebselen inhibits the bacterial translation process without affecting mitochondrial biogenesis. Additionally, ebselen was found to exhibit excellent activity in vivo in a Caenorhabditis elegans MRSA-infected whole animal model. Finally, ebselen showed synergistic activities with conventional antimicrobials against MRSA. Taken together, our results demonstrate that ebselen, with its potent antimicrobial activity and safety profiles, can be potentially used to treat multidrug resistant Gram-positive bacterial infections alone or in combination with other antibiotics and should be further clinically evaluated." @default.
• W1617971501 created "2016-06-24" @default.
• W1617971501 creator A5026553668 @default.
• W1617971501 creator A5029026650 @default.
• W1617971501 creator A5033537222 @default.
• W1617971501 date "2015-07-29" @default.
• W1617971501 modified "2023-10-16" @default.
• W1617971501 title "Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens" @default.
• W1617971501 cites W1640748652 @default.
• W1617971501 cites W1894441106 @default.
• W1617971501 cites W1978703019 @default.
• W1617971501 cites W1980275264 @default.
• W1617971501 cites W1981267913 @default.
• W1617971501 cites W1990484506 @default.
• W1617971501 cites W1990535513 @default.
• W1617971501 cites W1991471402 @default.
• W1617971501 cites W1991814996 @default.
• W1617971501 cites W1999979510 @default.
• W1617971501 cites W2005349464 @default.
• W1617971501 cites W2005472407 @default.
• W1617971501 cites W2006061844 @default.
• W1617971501 cites W2006609942 @default.
• W1617971501 cites W2022314846 @default.
• W1617971501 cites W2045761133 @default.
• W1617971501 cites W2055411163 @default.
• W1617971501 cites W2078006689 @default.
• W1617971501 cites W2080665741 @default.
• W1617971501 cites W2083580953 @default.
• W1617971501 cites W2091404988 @default.
• W1617971501 cites W2095719928 @default.
• W1617971501 cites W2098764224 @default.
• W1617971501 cites W2099402621 @default.
• W1617971501 cites W2099972396 @default.
• W1617971501 cites W2108260765 @default.
• W1617971501 cites W2115771487 @default.
• W1617971501 cites W2116707625 @default.
• W1617971501 cites W2117449266 @default.
• W1617971501 cites W2121448090 @default.
• W1617971501 cites W2128015417 @default.
• W1617971501 cites W2143949361 @default.
• W1617971501 cites W2145789959 @default.
• W1617971501 cites W2153062050 @default.
• W1617971501 cites W2153136603 @default.
• W1617971501 cites W2157572113 @default.
• W1617971501 cites W2157715080 @default.
• W1617971501 cites W2162000793 @default.
• W1617971501 cites W2163483026 @default.
• W1617971501 cites W2169457750 @default.
• W1617971501 cites W2169655887 @default.
• W1617971501 cites W2218466491 @default.
• W1617971501 cites W2417539104 @default.
• W1617971501 cites W2465845984 @default.
• W1617971501 cites W4236829767 @default.
• W1617971501 cites W86857350 @default.
• W1617971501 cites W966170180 @default.
• W1617971501 doi "https://doi.org/10.1371/journal.pone.0133877" @default.
• W1617971501 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4519285" @default.
• W1617971501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26222252" @default.
• W1617971501 hasPublicationYear "2015" @default.
• W1617971501 type Work @default.
• W1617971501 sameAs 1617971501 @default.
• W1617971501 citedByCount "57" @default.
• W1617971501 countsByYear W16179715012015 @default.
• W1617971501 countsByYear W16179715012016 @default.
• W1617971501 countsByYear W16179715012017 @default.
• W1617971501 countsByYear W16179715012018 @default.
• W1617971501 countsByYear W16179715012019 @default.
• W1617971501 countsByYear W16179715012020 @default.
• W1617971501 countsByYear W16179715012021 @default.
• W1617971501 countsByYear W16179715012022 @default.
• W1617971501 countsByYear W16179715012023 @default.
• W1617971501 crossrefType "journal-article" @default.
• W1617971501 hasAuthorship W1617971501A5026553668 @default.
• W1617971501 hasAuthorship W1617971501A5029026650 @default.
• W1617971501 hasAuthorship W1617971501A5033537222 @default.
• W1617971501 hasBestOaLocation W16179715011 @default.
• W1617971501 hasConcept C2778004101 @default.
• W1617971501 hasConcept C2778760513 @default.
• W1617971501 hasConcept C2778979269 @default.
• W1617971501 hasConcept C2778980435 @default.
• W1617971501 hasConcept C2779138974 @default.
• W1617971501 hasConcept C2779489039 @default.
• W1617971501 hasConcept C2780585763 @default.
• W1617971501 hasConcept C2781414143 @default.
• W1617971501 hasConcept C4937899 @default.
• W1617971501 hasConcept C501593827 @default.
• W1617971501 hasConcept C523546767 @default.
• W1617971501 hasConcept C54355233 @default.
• W1617971501 hasConcept C55493867 @default.
• W1617971501 hasConcept C86803240 @default.
• W1617971501 hasConcept C89423630 @default.
• W1617971501 hasConcept C98274493 @default.
• W1617971501 hasConceptScore W1617971501C2778004101 @default.
• W1617971501 hasConceptScore W1617971501C2778760513 @default.
• W1617971501 hasConceptScore W1617971501C2778979269 @default.
• W1617971501 hasConceptScore W1617971501C2778980435 @default.
• W1617971501 hasConceptScore W1617971501C2779138974 @default.
• W1617971501 hasConceptScore W1617971501C2779489039 @default.

• next